ArticleBritish journal of cancer2021

Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer.

Aikaterini Chatzipli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.